294 related articles for article (PubMed ID: 24560444)
21. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa.
Wallace K; Grau MV; Levine AJ; Shen L; Hamdan R; Chen X; Gui J; Haile RW; Barry EL; Ahnen D; McKeown-Eyssen G; Baron JA; Issa JP
Cancer Prev Res (Phila); 2010 Dec; 3(12):1552-64. PubMed ID: 21149331
[TBL] [Abstract][Full Text] [Related]
22. WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.
Bosch LJ; Luo Y; Lao VV; Snaebjornsson P; Trooskens G; Vlassenbroeck I; Mongera S; Tang W; Welcsh P; Herman JG; Koopman M; Nagtegaal ID; Punt CJ; van Criekinge W; Meijer GA; Monnat RJ; Carvalho B; Grady WM
Clin Cancer Res; 2016 Sep; 22(18):4612-22. PubMed ID: 27121793
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer.
Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y
Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760
[TBL] [Abstract][Full Text] [Related]
24. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.
Jia M; Zhang Y; Jansen L; Walter V; Edelmann D; Gündert M; Tagscherer KE; Roth W; Bewerunge-Hudler M; Herpel E; Kloor M; Ulrich A; Burwinkel B; Bläker H; Chang-Claude J; Brenner H; Hoffmeister M
Clin Epigenetics; 2019 Jul; 11(1):109. PubMed ID: 31340858
[TBL] [Abstract][Full Text] [Related]
25. EphA3 Downregulation by Hypermethylation Associated with Lymph Node Metastasis and TNM Stage in Colorectal Cancer.
Wang Y; Xuan Z; Wang B; Zhang D; Zhang C; Wang J; Sun Y
Dig Dis Sci; 2019 Jun; 64(6):1514-1522. PubMed ID: 30560328
[TBL] [Abstract][Full Text] [Related]
26. The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer.
Edin S; Wikberg ML; Dahlin AM; Rutegård J; Öberg Å; Oldenborg PA; Palmqvist R
PLoS One; 2012; 7(10):e47045. PubMed ID: 23077543
[TBL] [Abstract][Full Text] [Related]
27. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinoma.
Kumar A; Singh P; Pandey A; Gosipatala SB
Mol Biol Rep; 2020 Sep; 47(9):6919-6927. PubMed ID: 32929656
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer.
Gyparaki MT; Basdra EK; Papavassiliou AG
J Mol Med (Berl); 2013 Nov; 91(11):1249-56. PubMed ID: 24057814
[TBL] [Abstract][Full Text] [Related]
29. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of Barx2 predicts poor survival in colorectal cancer.
Mi Y; Zhao S; Zhang W; Zhang D; Weng J; Huang K; Sun H; Tang H; Zhang X; Sun X; Peng Z; Wen Y
Biochem Biophys Res Commun; 2016 Sep; 478(1):67-73. PubMed ID: 27453340
[TBL] [Abstract][Full Text] [Related]
31. Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.
Karpinski P; Walter M; Szmida E; Ramsey D; Misiak B; Kozlowska J; Bebenek M; Grzebieniak Z; Blin N; Laczmanski L; Sasiadek MM
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):201-8. PubMed ID: 23175427
[TBL] [Abstract][Full Text] [Related]
32. CpG island methylator phenotype is an independent predictor of survival after curative resection for colorectal cancer: A prospective cohort study.
Kim CH; Huh JW; Kim HR; Kim YJ
J Gastroenterol Hepatol; 2017 Aug; 32(8):1469-1474. PubMed ID: 28087988
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer.
Katoh H; Yamashita K; Waraya M; Margalit O; Ooki A; Tamaki H; Sakagami H; Kokubo K; Sidransky D; Watanabe M
Neoplasia; 2012 Jul; 14(7):559-71. PubMed ID: 22904674
[TBL] [Abstract][Full Text] [Related]
34. A novel CpG-methylation-based nomogram predicts survival in colorectal cancer.
Wang X; Wang D; Liu J; Feng M; Wu X
Epigenetics; 2020 Nov; 15(11):1213-1227. PubMed ID: 32396412
[TBL] [Abstract][Full Text] [Related]
35. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
36. DNA methylation profile in CpG-depleted regions uncovers a high-risk subtype of early-stage colorectal cancer.
Yu H; Wang X; Bai L; Tang G; Carter KT; Cui J; Huang P; Liang L; Ding Y; Cai M; Huang M; Liu H; Cao G; Gallinger S; Pai RK; Buchanan DD; Win AK; Newcomb PA; Wang J; Grady WM; Luo Y
J Natl Cancer Inst; 2023 Jan; 115(1):52-61. PubMed ID: 36171645
[TBL] [Abstract][Full Text] [Related]
37. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
38. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
[TBL] [Abstract][Full Text] [Related]
39. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
[No Abstract] [Full Text] [Related]
40. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps.
Cassinotti E; Melson J; Liggett T; Melnikov A; Yi Q; Replogle C; Mobarhan S; Boni L; Segato S; Levenson V
Int J Cancer; 2012 Sep; 131(5):1153-7. PubMed ID: 22020530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]